These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10371028)

  • 1. Pyrrolo[3,2-c]quinoline derivatives: a new class of kynurenine-3-hydroxylase inhibitors.
    Heidempergher F; Pevarello P; Pillan A; Pinciroli V; Della Torre A; Speciale C; Marconi M; Cini M; Toma S; Greco F; Varasi M
    Farmaco; 1999 Mar; 54(3):152-60. PubMed ID: 10371028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase.
    Giordani A; Pevarello P; Cini M; Bormetti R; Greco F; Toma S; Speciale C; Varasi M
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2907-12. PubMed ID: 9873646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
    Kravchenko DV; Kuzovkova YA; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Balakin KV; Ivachtchenko AV
    J Med Chem; 2005 Jun; 48(11):3680-3. PubMed ID: 15916416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
    Görlitzer K; Fabian J; Frohberg P; Drutkowski G
    Pharmazie; 2002 Apr; 57(4):243-9. PubMed ID: 11998442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 28833, a selective kynurenine 3-hydroxylase inhibitor. Effects on the kynurenine pathway metabolites in the gerbil.
    Cini M; Bormetti R; Marconi M; Molinari A; Veneroni O; Varasi M; Schwarcz R; Speciale C
    Adv Exp Med Biol; 1996; 398():535-8. PubMed ID: 8906318
    [No Abstract]   [Full Text] [Related]  

  • 6. Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase.
    Chiarugi A; Moroni F
    Neuropharmacology; 1999 Aug; 38(8):1225-33. PubMed ID: 10462134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a new class of potent pyrrolo[3,4-c]quinoline-1,3-diones based inhibitors of human dihydroorotate dehydrogenase: Synthesis, pharmacological and toxicological evaluation.
    Dimitrijević MG; Roschger C; Lang K; Zierer A; Paunović MG; Obradović AD; Matić MM; Pocrnić M; Galić N; Ćirić A; Joksović MD
    Bioorg Chem; 2024 Jun; 147():107359. PubMed ID: 38613925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and inhibitory activity of novel tri- and tetracyclic quinolines against topoisomerases.
    Sui Z; Altom J; Nguyen VN; Fernandez J; Bernstein JI; Hiliard JJ; Barrett JF; Podlogar BL; Ohemeng KA
    Bioorg Med Chem; 1998 Jun; 6(6):735-42. PubMed ID: 9681139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A convenient synthesis of 1H-pyrrolo[3,2-c]quinoline-6,9-diones and 11H-indolo[3,2-c]quinoline-1,4-diones derivatives.
    Helissey P; Parrot-Lopez H; Renault J; Cros S
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3547-57. PubMed ID: 3435963
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of the kynurine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine-3-hydroxylase.
    Pellicciari R; Amori L; Costantino G; Giordani A; Macchiarulo A; Mattoli L; Pevarello P; Speciale C; Varasi M
    Adv Exp Med Biol; 2003; 527():621-8. PubMed ID: 15206781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR of 4-aryl-2-hydroxy-4-oxobut-2-enoic acids and esters and 2-amino-4-aryl-4-oxobut-2-enoic acids and esters: potent inhibitors of kynurenine-3-hydroxylase as potential neuroprotective agents.
    Drysdale MJ; Hind SL; Jansen M; Reinhard JF
    J Med Chem; 2000 Jan; 43(1):123-7. PubMed ID: 10633043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantiospecific synthesis and in vitro activity of selective inhibitors of rat brain kynureninase and kynurenine-3-hydroxylase.
    Giordani A; Corti L; Cini M; Bormetti R; Marconi M; Veneroni O; Speciale C; Varasi M
    Adv Exp Med Biol; 1996; 398():531-4. PubMed ID: 8906317
    [No Abstract]   [Full Text] [Related]  

  • 13. Kynurenine-3-hydroxylase and its selective inhibitors. Molecular modeling studies.
    Costantino G; Mattoli L; Moroni F; Natalini B; Pellicciari R
    Adv Exp Med Biol; 1996; 398():493-7. PubMed ID: 8906310
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.
    Röver S; Cesura AM; Huguenin P; Kettler R; Szente A
    J Med Chem; 1997 Dec; 40(26):4378-85. PubMed ID: 9435907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenine hydroxylase and kynureninase inhibitors as tools to study the role of kynurenine metabolites in the central nervous system.
    Moroni F; Carpenedo R; Chiarugi A
    Adv Exp Med Biol; 1996; 398():203-10. PubMed ID: 8906267
    [No Abstract]   [Full Text] [Related]  

  • 16. 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors.
    Kravchenko DV; Kysil VV; Ilyn AP; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1841-5. PubMed ID: 15780618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE 28833 in rodents.
    Speciale C; Cini M; Wu HQ; Salvati P; Schwarcz R; Molinari A; Calabresi M; Varasi M
    Adv Exp Med Biol; 1996; 398():221-7. PubMed ID: 8906269
    [No Abstract]   [Full Text] [Related]  

  • 18. Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase.
    Chiarugi A; Carpenedo R; Moroni F
    J Neurochem; 1996 Aug; 67(2):692-8. PubMed ID: 8764597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold.
    Yu W; Deng Y; Sloman D; Li D; Liu K; Fradera X; Lesburg CA; Martinot T; Doty A; Ferguson H; Richard Miller J; Knemeyer I; Otte K; Vincent S; Sciammetta N; Jonathan Bennett D; Han Y
    Bioorg Med Chem Lett; 2021 Oct; 49():128314. PubMed ID: 34391891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo.
    Wu HQ; Guidetti P; Goodman JH; Varasi M; Ceresoli-Borroni G; Speciale C; Scharfman HE; Schwarcz R
    Neuroscience; 2000; 97(2):243-51. PubMed ID: 10799756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.